Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries-Reference-Cited by-同舟云学术

Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries

Published:2016-02-19 Issue:7 Volume:17 Page:921-936
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Garay Ricardo P.,Citrome Leslie,Samalin Ludovic,Liu Chen-Chung,Thomsen Morten S.,Correll Christoph U.,Hameg Ahcène,Llorca Pierre-Michel

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2016.1149164

Reference126 articles.

1. Definition and description of schizophrenia in the DSM-5

2. Physical illness and schizophrenia: a review of the literature

3. Humanistic burden in schizophrenia: A literature review

4. A Systematic Review and Meta-Analysis of Recovery in Schizophrenia

5. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions;Schizophrenia;2023-07-10

2. Recent clinical trials with stem cells to slow or reverse normal aging processes;Frontiers in Aging;2023-04-06

3. Motivation Disorders in Patients with Schizophrenia;Psikhiatriya;2022-09-29

4. Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond;Expert Review of Neurotherapeutics;2022-08-03

5. Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia;Neuroscience and Behavioral Physiology;2022-01